Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pertinent questions about H1N1 Influenza answered by NERAC

Municipalities in Massachusetts should assume that the H1N1 Influenza is now present in their communities, schools, and work places, and should take appropriate precautions to prevent the spread of this virus as well as the seasonal flu.

11 Dec 2009

Pharmacies to provide H1N1, seasonal flu and pneumonia vaccinations under TRICARE program

The Department of Defense today issued an interim final rule designating pharmacies as providers for H1N1, seasonal flu and pneumonia vaccinations under its TRICARE program.

11 Dec 2009

Four new H1N1 influenza vaccination clinics scheduled by Macomb County Health Department

Four new H1N1 influenza vaccination clinics have been scheduled by the Macomb County Health Department. Everyone over 6 months of age can receive the vaccine at these clinics. They are free of charge and will take place Dec. 14, 17, 19 and 21 at Bethesda Christian Church in Sterling Heights.

11 Dec 2009

Humidifiers may help in reducing flu virus

A newly-released scientific white paper suggests humidifiers may play an important role in reducing the survival of the flu virus on both surfaces and in the air.

11 Dec 2009

Researchers identify new biological pathway of H1N1 transmission to human population

A new biological pathway by which the H1N1 flu virus can make the jump from swine to humans has been discovered by researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley. Early test results indicate that a heretofore unknown mutation in one of the H1N1 genes may have played an important role in transmitting the virus into humans.

11 Dec 2009

Researchers find weakness in H1N1's method for evading detection by immune system

Researchers at Rice University and Baylor College of Medicine (BCM) have found what they believe is a weakness in H1N1's method for evading detection by the immune system.

11 Dec 2009

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

In a large Phase III clinical trial, Tasigna (nilotinib capsules) demonstrated greater efficacy over Gleevec (imatinib) in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The new clinical data were just presented as a late breaking abstract at the 51st annual meeting of the American Society of Hematology (ASH), in New Orleans, Louisiana.

11 Dec 2009

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%

11 Dec 2009

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

"Flu vaccine shortages in developing nations may destabilize global security should the H1N1 [swine flu] virus become more deadly … David Heymann, a former deputy head of the World Health Organization" said Monday, Bloomberg reports.

10 Dec 2009

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a comparative study of both treatments in patients with schizophrenia. Results of the 13-week clinical trial were released this week.

10 Dec 2009

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.

10 Dec 2009

Public health information website to provide information about advanced disinfectants launched

TouchSurfaces.Org launches a public health information website alerting visitors on how the hard surfaces in the home, the work place, and in public venues can act as host to a multitude of infectious viruses and bacteria including H1N1, MRSA, HIV, and others.

10 Dec 2009

Three innovative HHS ideas to protect and improve people’s health

HHS Secretary Kathleen Sebelius announced today three innovative HHS ideas that have been developed as a result of a more open and accessible federal decision making process in collaboration between the public, private sector and the federal government.

10 Dec 2009

Despite worldwide outbreak of H1N1 virus, American adults not eager to get vaccinated

American adults are not being vaccinated against the seasonal flu any more often than they were last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus, according to a new RAND Corporation study.

10 Dec 2009

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today released an independent laboratory report indicating that the company's BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against the H1N1 virus.

10 Dec 2009

Patients' urine may provide rapid diagnosis of pneumonia

Doctors may soon be able to quickly and accurately diagnose the cause of pneumonia-like symptoms by examining the chemicals found in a patient's urine, suggests a new study led by UC Davis biochemist Carolyn Slupsky.

10 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

Scientists discover the potential basis for urine test to diagnose CAP

Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.

10 Dec 2009

Nano Mask signs a three year agreement to distribute Wein Products respirators

Nano Mask, Inc. today announced that it has entered into a three year agreement with Wein Products, a manufacturer of disposable respirators, to distribute that company's products as it continues to complete the development of its own proprietary disposable NanoMask respirator and to obtain regulatory approval for the NanoMask.

10 Dec 2009

Washington Post, New York Times examine PEPFAR

The Washington Post examines the Obama administration's goal "to get the 'emergency' out of the President's Emergency Plan for AIDS Relief" and integrate HIV/AIDS programs more into the health infrastructure of recipient countries. A five-year strategy for PEPFAR was released last week.

9 Dec 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pertinent questions about H1N1 Influenza answered by NERAC

Pharmacies to provide H1N1, seasonal flu and pneumonia vaccinations under TRICARE program

Four new H1N1 influenza vaccination clinics scheduled by Macomb County Health Department

Humidifiers may help in reducing flu virus

Researchers identify new biological pathway of H1N1 transmission to human population

Researchers find weakness in H1N1's method for evading detection by immune system

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Public health information website to provide information about advanced disinfectants launched

Three innovative HHS ideas to protect and improve people’s health

Despite worldwide outbreak of H1N1 virus, American adults not eager to get vaccinated

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Patients' urine may provide rapid diagnosis of pneumonia

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Scientists discover the potential basis for urine test to diagnose CAP

Nano Mask signs a three year agreement to distribute Wein Products respirators

Washington Post, New York Times examine PEPFAR

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in